Abstract
Older adults with mild cognitive impairment (MCI) and dementia have cardiac comorbidities, making them eligible for device-based therapy for cardiac rhythm abnormalities.1-3 The risks and benefits of device implantation should be weighed carefully by pa tients with cognitive impairment, family members, and clinicians given the potential of these devices to have an impact on the quantity and quality of life. This study describes the epidemiology of cardiac implantable electronic devices among a population-based sample of older adults with and without cognitive impairment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have